Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2020
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
Pauline Krämer, Aline Talhouk, Mary Anne Brett, et al.
JAMA Network Open
|
February 2, 2026
Serous Ovarian Cancer Following Opportunistic Bilateral Salpingectomy
Ramlogan Sowamber, Alice J Mei, Paramdeep Kaur, et al.
Gynecologic Oncology
|
May 6, 2026
Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiative
Marcel Grube, Bianca Ribeiro de Souza, Andrea Neilson, et al.
Gynecologic Oncology
|
November 11, 2022
Profiling the immune landscape in mucinous ovarian carcinoma
Nicola S Meagher, Phineas Hamilton, Katy Milne, et al.
Gynecologic Oncology
|
June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis
Zhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
The Journal of Clinical Investigation
|
October 29, 2024
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
Brad H Nelson, Phineas Hamilton, Minh Tung Phung, et al.
The Journal of Pathology
|
December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas
Karolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases
Nicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
British Journal of Cancer
|
June 20, 2020
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
Filipe Correia Martins, Dominique-Laurent Couturier, Anna Paterson, et al.
British Journal of Cancer
|
November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study
Ashley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2020
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
Pauline Krämer, Aline Talhouk, Mary Anne Brett, et al.
JAMA Network Open
|
February 2, 2026
Serous Ovarian Cancer Following Opportunistic Bilateral Salpingectomy
Ramlogan Sowamber, Alice J Mei, Paramdeep Kaur, et al.
Gynecologic Oncology
|
May 6, 2026
Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiative
Marcel Grube, Bianca Ribeiro de Souza, Andrea Neilson, et al.
Gynecologic Oncology
|
November 11, 2022
Profiling the immune landscape in mucinous ovarian carcinoma
Nicola S Meagher, Phineas Hamilton, Katy Milne, et al.
Gynecologic Oncology
|
June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis
Zhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
The Journal of Clinical Investigation
|
October 29, 2024
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
Brad H Nelson, Phineas Hamilton, Minh Tung Phung, et al.
The Journal of Pathology
|
December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas
Karolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases
Nicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
British Journal of Cancer
|
June 20, 2020
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
Filipe Correia Martins, Dominique-Laurent Couturier, Anna Paterson, et al.
British Journal of Cancer
|
November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study
Ashley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Page
of 10